Nicholas Nikolopoulos - Net Worth and Insider Trading

Nicholas Nikolopoulos Net Worth

The estimated net worth of Nicholas Nikolopoulos is at least $650,464 dollars as of 2024-04-27. Nicholas Nikolopoulos is the EVP Chf Strategy & Growth Offi of Pediatrix Medical Group Inc and owns about 71,954 shares of Pediatrix Medical Group Inc (MD) stock worth over $650,464. Details can be seen in Nicholas Nikolopoulos's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nicholas Nikolopoulos has not made any transactions after 2020-09-15 and currently still holds the listed stock(s).

Transaction Summary of Nicholas Nikolopoulos

Nicholas Nikolopoulos Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nicholas Nikolopoulos owns 3 companies in total, including Pediatrix Medical Group Inc (MD) , Avaya Holdings Corp (AVYAQ) , and Avaya Holdings Corp (AVYAW) .

Click here to see the complete history of Nicholas Nikolopoulos’s form 4 insider trades.

Insider Ownership Summary of Nicholas Nikolopoulos

Ticker	Comapny	Transaction Date	Type of Owner
MD	Pediatrix Medical Group Inc	2020-09-15	EVP Chf Strategy & Growth Offi
AVYAQ	Avaya Holdings Corp	2018-01-16	SVP Corp Strategy & Dev & Mktng
AVYAW	Avaya Holdings Corp	2018-01-16	SVP Corp Strategy & Dev & Mktng

Nicholas Nikolopoulos Latest Holdings Summary

Nicholas Nikolopoulos currently owns a total of 1 stock. Nicholas Nikolopoulos owns 71,954 shares of Pediatrix Medical Group Inc (MD) as of September 15, 2020, with a value of $650,464.

Latest Holdings of Nicholas Nikolopoulos

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
MD	Pediatrix Medical Group Inc	2020-09-15	71,954	9.04	650,464

Holding Weightings of Nicholas Nikolopoulos

Nicholas Nikolopoulos Form 4 Trading Tracker

According to the SEC Form 4 filings, Nicholas Nikolopoulos has made a total of 1 transactions in Pediatrix Medical Group Inc (MD) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Pediatrix Medical Group Inc is the sale of 10,000 shares on September 15, 2020, which brought Nicholas Nikolopoulos around $190,200.

Insider Trading History of Nicholas Nikolopoulos

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nicholas Nikolopoulos Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nicholas Nikolopoulos Ownership Network

Ownership Network List of Nicholas Nikolopoulos

No Data

Ownership Network Relation of Nicholas Nikolopoulos

Nicholas Nikolopoulos Owned Company Details

What does Pediatrix Medical Group Inc do?

Who are the key executives at Pediatrix Medical Group Inc?

Nicholas Nikolopoulos is the EVP Chf Strategy & Growth Offi of Pediatrix Medical Group Inc. Other key executives at Pediatrix Medical Group Inc include EVP & Chief Operating Officer James D Swift , EVP Chief ERM/Legal Ops Off Moore Mary Ann E , and director & Chief Executive Officer Mark S Ordan .

Pediatrix Medical Group Inc (MD) Insider Trades Summary

Over the past 18 months, Nicholas Nikolopoulos made no insider transaction in Pediatrix Medical Group Inc (MD). Other recent insider transactions involving Pediatrix Medical Group Inc (MD) include a net sale of 42,957 shares made by James D Swift , a net sale of 55,166 shares made by Mark S Ordan , and a net sale of 19,000 shares made by Shirley A Weis .

In summary, during the past 3 months, insiders sold 0 shares of Pediatrix Medical Group Inc (MD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 119,243 shares of Pediatrix Medical Group Inc (MD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 119,243 shares.

Pediatrix Medical Group Inc (MD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pediatrix Medical Group Inc Insider Transactions

No Available Data

What does Avaya Holdings Corp do?

Who are the key executives at Avaya Holdings Corp?

Nicholas Nikolopoulos is the SVP Corp Strategy & Dev & Mktng of Avaya Holdings Corp. Other key executives at Avaya Holdings Corp include 10 percent owner King Theodore Walker Cheng-de , GVP & Human Resources Anna-marie Crowley , and SVP & General Counsel Vito Carnevale .

Avaya Holdings Corp (AVYAQ) Insider Trades Summary

Over the past 18 months, Nicholas Nikolopoulos made no insider transaction in Avaya Holdings Corp (AVYAQ). Other recent insider transactions involving Avaya Holdings Corp (AVYAQ) include a net sale of 4,762,918 shares made by King Theodore Walker Cheng-de ,

In summary, during the past 3 months, insiders sold 0 shares of Avaya Holdings Corp (AVYAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,762,918 shares of Avaya Holdings Corp (AVYAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,762,918 shares.

Avaya Holdings Corp (AVYAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avaya Holdings Corp Insider Transactions

No Available Data

What does Avaya Holdings Corp do?

Who are the key executives at Avaya Holdings Corp?

Nicholas Nikolopoulos is the SVP Corp Strategy & Dev & Mktng of Avaya Holdings Corp. Other key executives at Avaya Holdings Corp include GVP & Human Resources Anna-marie Crowley , SVP & General Counsel Vito Carnevale , and Interim CFO Rebecca A Roof .

Avaya Holdings Corp (AVYAW) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Avaya Holdings Corp (AVYAW) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Avaya Holdings Corp (AVYAW) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Avaya Holdings Corp (AVYAW)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avaya Holdings Corp Insider Transactions

No Available Data

Nicholas Nikolopoulos Mailing Address

Above is the net worth, insider trading, and ownership report for Nicholas Nikolopoulos. You might contact Nicholas Nikolopoulos via mailing address: Mednax Inc, 1301, Sunrise Fl 33323.

Discussions on Nicholas Nikolopoulos

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.